Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 22, 2013

Bayer, Biogen Idec, DelMar, Janssen, J&J, Pfizer, Regeneron, Sanofi, Threshold

Phase I
DelMar presents dose-escalation interim results . . . read more

No dose-limiting toxicity in Threshold study . . . read more

Phase III
Sanofi, Regeneron RA drug shows effectiveness . . . read more

Filings
Biogen idec drug gets protection in EU . . . read more

Eylea approved in Japan . . . read more

J&J diabetes treatment approved in EU . . . read more

Xalkori gets full approval . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters